DoD Breast Cancer Clinical Research Extension Award
ID: 358732Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358732
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Breast Cancer Clinical Research Extension Award as part of the Fiscal Year 2025 Breast Cancer Research Program (BCRP). This grant aims to enhance the impact of breast cancer clinical studies by extending data collection, follow-up, and analysis, specifically addressing challenges such as early trial termination and limited patient follow-up. Approximately $26.35 million is available to fund around three projects, with direct cost caps of $5 million for single Principal Investigators (PIs) and $6 million for partnered PIs, requiring the involvement of at least two breast cancer consumer advocates in the research team. Interested applicants must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025, with successful proposals notified within six weeks post-review. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525BCRPCREA_GG.pdf
    The Department of Defense's Fiscal Year 2025 (FY25) Breast Cancer Research Program (BCRP) Clinical Research Extension Award aims to enhance the impact of breast cancer clinical studies by expanding data collection and analysis. Approximately $26.35 million is allocated to fund around three projects, with direct cost caps of $5 million for single Principal Investigators (PIs) and $6 million for those applying as partnered PIs. Eligible applicants include various organizations, both domestic and foreign, with a requirement for involvement from at least two breast cancer consumer advocates. The award seeks to address critical challenges in breast cancer research, including prevention, understanding cancer behavior, and improving treatment regimens. Research proposals should demonstrate scientific merit, including a solid rationale backed by preliminary data and a detailed data-sharing plan. The application process involves a two-step submission: a pre-application due by June 13, 2025, followed by a full application by June 27, 2025. Applications will undergo a peer review process focusing on impact, research strategy, personnel qualifications, and partnership dynamics when applicable. Successful applicants will receive notification within six weeks after the programmatic review of their proposals.
    Similar Opportunities
    DoD Breast Cancer Breakthrough Award Levels 1 and 2
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Research Program (BCRP) Breakthrough Award Levels 1 and 2, aimed at supporting innovative research with the potential to significantly advance breast cancer treatment and prevention. This funding opportunity, totaling approximately $37.7 million, seeks to address critical challenges in breast cancer research, including prevention strategies, understanding metastasis, and improving treatment efficacy. Eligible applicants include both domestic and foreign nonprofit and for-profit organizations, with a strong emphasis on collaborative partnerships, particularly those involving military and veteran populations. Interested parties must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DoD Breast Cancer Breakthrough Award Level 3
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Breakthrough Award Level 3, aimed at supporting innovative research with the potential to significantly advance breast cancer treatment and prevention. Applicants are required to address at least one of the Department of Defense-defined challenges related to breast cancer, and the research team must include breast cancer consumer advocates to ensure patient perspectives are integrated into the research process. This grant program allocates approximately $27.9 million for three awards, with funding caps of $4 million for single Principal Investigators and $5 million for projects involving a Partnering PI. Pre-applications are due by June 13, 2025, and full applications must be submitted by September 10, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Breast Cancer Era of Hope Scholar Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Research Program's Era of Hope Scholar Award, aimed at early-career scientists with the potential to innovate in breast cancer research. This grant program, with an estimated total funding of approximately $10.85 million, will support two awards, each capped at $3.5 million for a maximum term of four years. The award emphasizes the importance of innovative research approaches to advance understanding and treatment of breast cancer, requiring Principal Investigators to commit at least 25% of their time to the project and to include two breast cancer consumer advocates in their research teams. Interested applicants must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Clinical Trial Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity for the fiscal year 2025 under the Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA). This grant aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment, specifically targeting designated cancer types relevant to military health. The program emphasizes the importance of advancing cancer research to benefit service members, veterans, and their families, with funding available for projects ranging from initial proof-of-concept trials to large-scale phase III trials, capped at a total cost of $4.2 million over a maximum performance period of four years. Interested applicants must submit pre-applications by June 20, 2025, followed by full applications due by September 25, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Peer Reviewed Cancer, Idea Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the fiscal year 2025 Peer Reviewed Cancer Research Program (PRCRP) Idea Award to support innovative cancer research that prioritizes military health. This grant aims to fund high-risk, high-reward proposals that focus on specific cancer types relevant to Service Members, Veterans, and their families, with an emphasis on introducing new paradigms in cancer care and addressing environmental exposure risks. With an estimated total program funding of approximately $14 million, the program anticipates awarding around 25 projects, each with a maximum funding limit of $560,000 for a duration of up to two years. Interested applicants must submit a pre-application by June 20, 2025, followed by a full application due by September 25, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Impact Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Cancer Research Program (PRCRP) Impact Award to support high-impact research aimed at improving clinical cancer care relevant to military health. This grant seeks mature research projects that demonstrate potential for near-term benefits in cancer treatment and patient outcomes, particularly focusing on specific cancer types such as bladder, blood, and brain cancers, while excluding melanoma and breast cancers. The program emphasizes the importance of preliminary data, collaboration with Department of Defense (DOD) and Veterans Affairs (VA) entities, and rigorous study designs to advance cancer detection and treatment for service members and their families. The estimated total program funding is $45.5 million, with individual awards capped at $1.4 million for single Principal Investigator applications and $1.75 million for partnering applications, over a maximum period of three years. Interested applicants must submit a pre-application by September 25, 2025, and can contact the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Prostate Cancer, Clinical Consortium Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2025 Prostate Cancer Research Program Clinical Consortium Award, aimed at advancing clinical trials for novel therapeutic interventions in prostate cancer. This grant supports the establishment of a consortium of leading researchers across multiple institutions to expedite the clinical advancement of treatments, with a focus on understanding disease progression, improving patient quality of life, and ensuring equitable access to care for high-risk populations. The total estimated funding for this opportunity is approximately $36.8 million, with $12.2 million allocated for one Coordinating Center and $24.6 million for up to eleven clinical research sites, each with specific funding caps and a duration of four years. Interested applicants must submit a pre-application by August 8, 2025, followed by a full application by August 29, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Ovarian Cancer, Investigator-Initiated Research Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award for fiscal year 2025. This grant aims to support innovative research that addresses critical needs in ovarian cancer care, with a focus on areas such as ovarian cancer biology, novel therapies, prevention strategies, early detection, and enhancing patient survivorship. The program is significant for advancing ovarian cancer research and improving care for service members and the broader community. Interested applicants can submit a pre-application by June 12, 2025, with full applications due by September 11, 2025. The estimated total program funding is $8,050,000, with individual awards up to $1.05 million for single Principal Investigators and $1.4 million for partnering PIs, and preliminary data is required to demonstrate the scientific validity of the proposed research. For further inquiries, applicants can contact the CDMRP Help Desk at 301-682-5507 or via email at help@eBRAP.org.
    DoD Rare Cancers, Idea Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Rare Cancers Research Program (RCRP) Idea Development Award for fiscal year 2025. This grant aims to support innovative research that explores new ideas and develops impactful strategies in the area of rare cancers, which are defined as those affecting six or fewer individuals per 100,000 annually in the U.S. Eligible applicants include various organizations, and the program encourages interdisciplinary collaboration among military, academic, and industry sectors to enhance health outcomes for military Service Members, Veterans, and the broader public. The total estimated program funding is $6,860,000, with a funding limit of $490,000 per application. Key deadlines include a pre-application due by July 1, 2025, and a full application by October 6, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Cancer Research Program (PRCRP) Career Development Award, specifically targeting early-career researchers via Fellow and Resident Options. This grant aims to support advancements in cancer research by funding projects that address critical issues relevant to military health, with a focus on specific PRCRP topic areas such as blood, gastroenterological, and neurological cancers. The total estimated funding for this initiative is approximately $6.72 million, with funding caps of $280,000 for one-year Resident projects and $560,000 for three-year Fellow projects. Interested applicants must submit a pre-application by June 19, 2025, followed by a full application due by July 3, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.